1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
Global Diagnostic Imaging Industry

Global Diagnostic Imaging Industry

  • September 2020
  • 537 pages
  • ID: 5798349
  • Format: PDF
  • Global Industry Analysts


Table of Contents


Timely market intelligence is paramount in these uncertain times!

We launched an impact survey to update this project with timely insights during 2020. Update frequency will depend upon evolving market conditions and executive opinions. Our participants are executives driving strategy, marketing, sales and product management at competitive companies worldwide. All updates during the rest of the year are complimentary to clients!

The global market for Diagnostic Imaging is projected to reach US$31.8 billion by 2025, driven by the importance of medical imaging in healthcare in disease prevention, early detection, diagnosis, and treatment. Essential in the management of all virtually all medical conditions and diseases, there is growing interest in R&D of newer and more powerful imaging technologies. Advanced imaging capabilities provide huge benefits such as early detection; better diagnosis; detailed visualization of anatomical structures; easy and faster physician understanding of disease complications; better clinical decisions; reduced risk of errors; safer in terms of medical radiation exposure; and better patient outcome. Demand for diagnostic imaging services is poised to benefit from the growing global burden of disease which is directly linked to increasing life expectancy. With the average human living longer due to improvements in acute care, the risk of developing chronic diseases remains high leading to higher number of years lived with disability. Medications that slow progress of disease and prevent death such as BP, cholesterol drugs for cardiovascular diseases and new generation drugs for diabetics are responsible for the rise in life expectancy. For instance, drugs like Metformin has significantly increased survival rate in patients with diabetes and comorbid heart diseases. However, prolonged life with chronic diabetes leads to other diabetes-related health problems such as damage to eyes, kidneys, feet, nerves, large blood vessels of the heart, brain and legs. Higher number of years lived in less-than-ideal health pushes up demand for healthcare services. With medical imaging being the starting point for timely care and treatment, diagnostic imaging is the chief beneficiary of the aging population living with chronic diseases.

Popular diagnostic imaging technologies currently in use include X-rays, CT scan (computed tomography scan), MRI (magnetic resonance imaging), ultrasound, nuclear medicine imaging, including positron-emission tomography (PET), and optical imaging. The field of diagnostic imaging is effervescent and continuously evolving and changing with significant funds for R&D being continuously injected to develop more advanced imaging technologies that provide accurate and precise diagnosis. Few of the ongoing innovations include hybrid imaging technology that combines PET/CT, PET/MRI and/or SPECT/CT systems; development of imaging systems with lower doses of ionizing radiation or non-ionizing radiation such as Optical Coherence Tomography (OCT), Photoacoustic Imaging, Diffuse Optical Tomography (DOT), Raman Spectroscopy & Photoactivated Localization Microscopy (PALM), Florescence Imaging, Near-infrared fluorescence imaging, Bioluminescent Imaging (BLI); use of contrast Agents in diagnostic imaging; development of cryogen-free MRI imaging systems and automated CT scanners, among others. Nuclear imaging market is especially poised to grow supported by the epidemic spread of cancer. Nuclear medicine is an evolving area of radiology that utilizes tiny amounts of radioactive dye (tracer) to highlight damaged or infected tissues and cancer cells. Types of nuclear imaging modalities that utilize radioisotopes include bone density scan, Cardiac PET perfusion, Cardiac PET sarcoid, Cardiac SPECT perfusion, Cardiac PET viability, PET/CT scanning, MIBG (metaiodobenzylguanidine) scans, gallium scan, and SPECT. Nuclear imaging equipment, over the decades, has witnessed several advances at the technological front. Technological advances continue to drive the market, with some of these focusing in improving systems in order to enhance clinical decision-making for clinicians as well as patients. Rising density of diagnostic imaging units is resulting in growing number of imaging procedures performed each day. CT & MRI scans dominate the diagnostic radiology industry, with the United States leading the world in terms of volume of procedures performed. The United States and Europe represent large markets worldwide with a combined share of 59% of the market. China ranks as the fastest growing market with a CAGR of 7.6% over the analysis period supported by the country’s rapidly developing healthcare system under the “Healthy China 2020” initiative which is largely focused on chronic disease prevention.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on